Skip to main content

Work Begins on Massive TMC3 Project

Published Aug 31, 2021 by A.J. Mistretta

TMC3 Aerial July 2022

Aerial rendering of TMC3

Work has begun on TMC3, the much-anticipated life sciences research and commercialization campus that backers believe will become a robust global nexus for that work in the years to come. 

The Texas Medical Center announced on August 31 that construction has begun on phase one of the 37-acre project, which is backed by $1.8 billion in secured financing. The full TMC3 master plan, set to materialize over several years, spans more than 6 million square feet of development. Officials say TMC3 will result in 42,000 new jobs and an annual economic impact of $5.4 billion. 

Phase one will include 950,000 square feet dedicated to translational research anchored by Boston-based Beacon Capital Partners and its strategic partner Braidwell, a life sciences-focused investment firm. The first phase will also include a 500+ room hotel with more than 650,000 square feet of conference space, a 350-unit residential tower, parking and nearly 19 acres of public space including parks. 

“With more than 100,000 employees, vast intellectual capital and a long-standing patient focus, our capacity for innovation is second to none,” said William McKeon, President & CEO of TMC. “The collective power of TMC’s hospitals and academic institutions has accelerated the pace of scientific discovery for years. TMC3 extends our collaboration to Fortune 100 life sciences companies and entrepreneurial ventures. The impact on patients worldwide has the potential to be nothing short of life-changing.”

TMC3 was designed by Boston-based Elkus Mafredi Architects, which has designed several of Massachusetts’ major life sciences complexes. According to a release from TMC: “The plan emphasizes creative collisions between people, institutions, and ideas, bolstered by a state-of-the-art infrastructure that will support a mix of healthcare, life science and business users. In addition, purposeful, growth focused capital investments will foster an ever-expanding network of business partners, from entrepreneurial ventures to Fortune 100 companies.”

TMC3's founding institutions — the TMC, Baylor College of Medicine, Texas  A&M University Health Science Center, the University of Texas Health Science Center at Houston and the University of Texas M.D. Anderson Cancer Center — will each have their own dedicated facilities on the campus when its complete.
 

Learn more about TMC3 and life sciences in Houston. 

Related News

Economic Development

Houston Region Asserts Biotech Excellence at BIO International Convention

6/25/25
The Greater Houston Partnership and regional partners showcased Houston’s thriving life sciences and biotechnology ecosystem at the 2025 BIO International Convention in Boston. As the premier annual biotechnology conference in the United States, BIO 2025 drew nearly 20,000 global attendees, offering a powerful platform to highlight the region’s momentum, innovation, and growing opportunities in the sector.    BioHouston, Galveston EDP, Partnership Lake Houston, Pearland EDC, the Sugar Land Office of Economic Development and Tourism and The Woodlands EDP presented the many assets and unique benefits the region offers to biotechnology companies from startup to full-scale, including 8 million square feet of life sciences space, strategic workforce and educational initiatives, as well as an overall favorable approach to incentives and permitting.    "Working alongside the different members of our region and telling the story of the amazing product that Greater Houston has to offer is invigorating," Galveston EDP Executive Director Joshua Owens said. "Being able to showcase our ecosystem to a worldwide audience is an exceptional step toward creating opportunities for the people of Houston."    Recent wins, such as Bionova Scientific's move to The Woodlands and United Therapeutics’ move to Generation Park, serve as testaments to the variety of options for life science businesses in our region. With pronounced capabilities in research and development, manufacturing and innovation, life sciences companies of all kinds can find a welcoming home in the Houston region.    To learn more about our life sciences and biotechnology ecosystem, visit our life sciences page. 
Read More
Economic Development

San Jacinto College and CellReady Launch Program to Accelerate Cell Therapy Workforce Development

12/17/24
[PRESS RELEASE Provided by SanJac] PASADENA, Texas – The San Jacinto College Center for Biotechnology has partnered with CellReady, a privately held cell therapy contract development and manufacturing organization, to launch an innovative, fast-track training curriculum for new hires in biomanufacturing. This four-week program is designed to significantly shorten onboarding time for manufacturing associates, providing them with concentrated and rigorous hands-on training to jumpstart their readiness to work in advanced cell therapy manufacturing. Over the course of the program, trainees undergo 160 hours of both theoretical and practical, hands-on learning that cover the fundamentals of biomanufacturing through the operation of advanced workflows. The curriculum prepares new hires for the production of cell therapies, a cutting-edge cancer treatment, using the G-Rex cell production platform. The training, which took place at CellReady’s manufacturing site in Houston, was delivered by San Jacinto College Biotechnology faculty members, in collaboration with CellReady’s training team. “To our knowledge, this is the first collaboration of its kind between a community college and a cell therapy manufacturer to develop an intensive onboarding curriculum tailored specifically for cell therapy manufacturing technicians,” said Dr. Chris Wild, San Jacinto College assistant vice chancellor of biotechnology. “Together with CellReady, we’ve created a path to rapidly train professionals with advanced, hands-on techniques, using the G-Rex cell production platform, which is widely used in the industry today.” This joint initiative provides clear benefits to all stakeholders. For San Jacinto College, it underscores the institution’s commitment to meeting industry needs with innovative, real-world training.  CellReady gains a streamlined, effective approach to onboarding that enables new technicians to make an immediate impact post-training. At the conclusion of the program, trainees are equipped with the skills and knowledge needed to manufacture cell therapies. Dr. Ignacio Nunez, CellReady’s chief operating officer, was impressed with the training provided and the speed that employees were able to grasp the critical components of the manufacturing process, stating “Thanks to the training program developed and delivered by San Jacinto College and CellReady, we were able to provide our new hires with the essential knowledge and skills to work in a GMP environment. In collaboration with San Jacinto College, we have debottlenecked operator qualification and made great strides toward our mission of bringing more of these life-saving therapies to patients one G-Rex at a time.” “This program not only equips new team members with qualifiable skills to contribute immediately upon completion of the training program, but it also sets a new standard for how training can be delivered in a highly regulated field,” said Dr. Nicole Bradley, program director for the Center for Biotechnology. The program’s success has inspired plans for additional training sessions to onboard future manufacturing professionals at CellReady, further strengthening the relationship between San Jacinto College and CellReady. The training curriculum for cell therapy developed in collaboration with this industry leader will be available as a program offering through the San Jacinto Center for Biotechnology. About CellReady CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About San Jacinto College Surrounded by monuments of history, evolving industries, maritime enterprises of today, and the space age of tomorrow, San Jacinto College has served the people of East Harris County, Texas, since 1961. The College is one of the top 10 community colleges in the nation as designated by the Aspen Institute and was named an Achieving the Dream Leader College of Distinction in 2020. The College is a Hispanic-Serving Institution that spans five campuses, serving approximately 45,000 credit and non-credit students annually. It offers more than 200 degrees and certificates across eight major areas of study that put students on a path to transfer to four-year institutions or enter the workforce. The College is fiscally sound, holding bond ratings of AA+ by Standard & Poor’s and Aa2 by Moody’s.
Read More

Related Events

Executive Partners